Answers are grounded in this paper and cite their sources.
Objective: The aim of the study was to assess patients’ perceptions of pDPN while on gabapentinoid therapy, evaluate their quality of life, and identify differences between patient and physician perceptions regarding the characterization and severity of pDPN symptoms.Methodology: A cross-sectional descriptive study was conducted at neurology departments of Ziauddin University, Karachi and Shifa Tameer e Millat University, Islamabad from September 2023 to December 2023 Patients with clinically diagnosed painful diabetic peripheral neuropathy (pDPN) undergoing gabapentinoid treatment were recruited using convenience sampling (1,891 patients) as were physicians who managed patients with diabetic neuropathy (460 physicians). Data were collected through structured questionnaires administered to patients with clinically diagnosed pDPN and physicians managing diabetic neuropathy. Descriptive statistics were used to summarize demographic characteristics, awareness, misconceptions, communication patterns, symptom perception, and quality-of-life findingsResults: A total of 1,891 patients and 460 physicians participated. Awareness of DPN was low, with 37.8% patients having no idea what DPN was and 51.3% patients having little knowledge. Regarding health-related quality of life, 42.1% of the respondents rated their general health as bad or fair, and 73.6% reported some limitations in moderate physical activities, 87.1% reported limitations in climbing several flights of stairs, and 77.9% reported pain-related interference with normal activities to some extent. There was a difference in detailed symptom discussion, with 15.5% of patients versus 34.3% of physicians reporting such discussions. Patients reported pins and needles sensations as compared to physicians at a rate of 30.8% versus 22.2%, respectively, and a major impact of pDPN on daily activity was reported by 20.7% of patients versus 90.2% of physicians, respectively. There were also some misconceptions such as 45.4% who believed that most DPN patients need amputation and 43.3% who believed that nothing could be done to treat DPN symptoms.Conclusion: Differences were observed between patient-reported experiences and physician perceptions of pDPN in Pakistan. Underrecognition of symptoms, poor communication, and pervasive misconceptions may contribute to delayed diagnosis and suboptimal management.
No takes yet. Share an insight, caveat, or question.
Soomro et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: